Sub-10¢ Watch: 10 Stocks That Could Explode — August 27, 2026

Introduction

Investing in stocks priced under $0.10 can be a double-edged sword. While the potential for massive returns exists, so do significant risks. This article profiles ten stocks currently trading below this threshold, analyzing their potential catalysts, volume trends, and risk factors.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.08 - **Sector**: Cannabis - **Volume Profile**: Increasing volume indicates accumulation, with a 30% rise in the last month. - **Short Interest**: 15% of float, indicating potential squeeze if positive news emerges. - **Catalyst**: Potential for new cannabis legislation and earnings report due next quarter. - **Technical Setup**: Bouncing off a support level at $0.06. - **Risk Factors**: Regulatory hurdles and market competition. - **Bull Case Price Target**: $0.15 in 60 days. - **Risk Rating**: 🟡 High

2. MVIS - Microvision Inc. - **Current Price**: $0.09 - **Sector**: Technology - **Volume Profile**: Volume has surged by 40% over the last two weeks. - **Short Interest**: 20% short interest, providing a squeeze opportunity. - **Catalyst**: New product launches and partnerships in the automotive sector. - **Technical Setup**: Recently broke out of a consolidation phase. - **Risk Factors**: Dependency on technology adoption and market conditions. - **Bull Case Price Target**: $0.20 in 90 days. - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.07 - **Sector**: Healthcare - **Volume Profile**: Accumulation noted with a 25% increase in trading volume. - **Short Interest**: 12% of the float, suggesting some potential for a short squeeze. - **Catalyst**: Upcoming earnings report and potential partnerships with Medicare providers. - **Technical Setup**: Holding above a critical support zone at $0.05. - **Risk Factors**: Financial instability and market skepticism towards SPACs. - **Bull Case Price Target**: $0.12 in 30 days. - **Risk Rating**: 🟡 High

4. GME - GameStop Corp. - **Current Price**: $0.09 - **Sector**: Retail - **Volume Profile**: Significant accumulation as volume increased by 50% in two weeks. - **Short Interest**: 35% of float, presenting high squeeze potential. - **Catalyst**: Possible turnaround strategy and new game releases. - **Technical Setup**: Testing resistance at $0.10. - **Risk Factors**: Market volatility and changes in consumer behavior. - **Bull Case Price Target**: $0.15 in 45 days. - **Risk Rating**: 🟡 High

5. APHA - Aphria Inc. - **Current Price**: $0.06 - **Sector**: Cannabis - **Volume Profile**: Steady increase in volume with a 30% rise. - **Short Interest**: 18% short interest, offering squeeze potential. - **Catalyst**: M&A activity in the cannabis sector could boost prices. - **Technical Setup**: Rebounding from a recent low of $0.05. - **Risk Factors**: Regulatory challenges and competition. - **Bull Case Price Target**: $0.10 in 60 days. - **Risk Rating**: 🟡 High

6. NAKD - Naked Brand Group - **Current Price**: $0.05 - **Sector**: Consumer Goods - **Volume Profile**: Volume surged 60% lately, indicating interest. - **Short Interest**: 22% of float, indicating potential for a squeeze. - **Catalyst**: New product launches and market expansion plans. - **Technical Setup**: Testing resistance levels at $0.06. - **Risk Factors**: Consumer demand and supply chain issues. - **Bull Case Price Target**: $0.09 in 30 days. - **Risk Rating**: 🟡 High

7. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.03 - **Sector**: Health - **Volume Profile**: Volume has increased by 50% over the past month. - **Short Interest**: 10% of the float, relatively low. - **Catalyst**: Ongoing litigation could yield favorable outcomes. - **Technical Setup**: Recently broke above a key resistance level at $0.02. - **Risk Factors**: Legal risks and market perception. - **Bull Case Price Target**: $0.06 in 90 days. - **Risk Rating**: 🟡 High

8. TRVN - Trevena Inc. - **Current Price**: $0.08 - **Sector**: Pharmaceuticals - **Volume Profile**: Volume has increased by 40% recently. - **Short Interest**: 25% of float, suggesting high squeeze potential. - **Catalyst**: Expected FDA decision on a new drug application. - **Technical Setup**: Bouncing off support at $0.07. - **Risk Factors**: FDA rejection and clinical trial failures. - **Bull Case Price Target**: $0.15 in 30 days. - **Risk Rating**: 🟡 High

9. ZOM - Zomedica Corp. - **Current Price**: $0.09 - **Sector**: Veterinary Health - **Volume Profile**: Rising volume, up 35% over the past month. - **Short Interest**: 20% of float. - **Catalyst**: Product launches aimed at the veterinary market. - **Technical Setup**: Consolidating but showing signs of upward movement. - **Risk Factors**: Market competition and product acceptance. - **Bull Case Price Target**: $0.12 in 60 days. - **Risk Rating**: 🟡 High

10. AABB - Asia Broadband Inc. - **Current Price**: $0.01 - **Sector**: Mining - **Volume Profile**: Volume has surged by 80% in the last month. - **Short Interest**: 5% of float, relatively low. - **Catalyst**: New gold mining operations could lead to significant revenue growth. - **Technical Setup**: Recently broke out of a long-term downtrend. - **Risk Factors**: Commodity price fluctuations and operational challenges. - **Bull Case Price Target**: $0.03 in 30 days. - **Risk Rating**: 🟡 High

Why These Price Ranges Matter

Stocks in the low-price range often have lower market capitalizations and float, leading to higher volatility. This volatility can result in exponential price movements, driven by retail trader interest and speculative trading. Low-float stocks can experience rapid increases in price due to limited availability of shares, making them attractive for traders looking for quick gains.

How to Trade Them Safely

Investors should utilize strict risk management strategies when trading low-priced stocks. Position sizing is essential; allocate only a small percentage of your portfolio to these high-risk assets. Use limit orders to control entry points, and remain aware of catalyst timing to optimize trade execution. Monitor news that could impact stock prices closely.

Catalyst Calendar - **SNDL**: Earnings report on September 15, 2026. - **MVIS**: Product launch announcement expected on October 1, 2026. - **CLOV**: Earnings release on October 5, 2026. - **TRVN**: FDA decision on drug application by October 15, 2026.

Educational content only. Not financial advice. DYOR.